| Financial Year |
March 31 2023 |
| Monetary Funds |
18,831,974,317.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,455,095,100.55 |
| Advances to Suppliers |
94,008,722.39 |
| Other Receivables |
1,349,598,289.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,327,395,775.12 |
| Inventories |
418,041,381.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
196,889,998.07 |
| Total Current Assets |
22,347,107,809.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,588,626,934.82 |
| Investment Properties |
-- |
| Fixed Assetes |
9,500,763,196.04 |
| Under-construction Projects |
508,700,661.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,401,006,127.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
167,817,903.76 |
| Sub-Total of Non-Current Assets |
20,104,151,352.02 |
| Total Assets |
42,451,259,161.15 |
| Short-Term Loans |
930,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,322,218,268.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
430,472,605.05 |
| Taxes Payable |
591,812,525.88 |
| Interest Payable |
-- |
| Dividend Payable |
1,869,280,000.00 |
| Other payables |
3,689,118,935.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,809,688,137.96 |
| Other Current Liabilities |
91,914,890.73 |
| Sub-Total of Current Liabilities |
15,572,262,984.56 |
| Long-term Loans |
2,178,000,000.00 |
| Bonds Payable |
1,000,000,000.00 |
| Long-Term Accounts Payable |
30,247.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
658,545,637.58 |
| Deferred Income Tax Liabilities |
60,388,292.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,368,473,278.96 |
| Total Liabilities |
19,940,736,263.52 |
| Paid-In Capital(Or Share Stock) |
1,673,700,000.00 |
| Capital Surplus |
150,904,250.42 |
| Surplus Reserve |
1,020,186,520.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
11,024,432,917.31 |
| Minority Stockholder's Interest |
7,078,332,908.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,432,189,989.61 |
| Owner's Equity（Stockholder's Equity） |
22,510,522,897.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,451,259,161.15 |
